Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2600135195Phase 4Not yet recruiting
Phase 4, randomised, open-label trial of lidocaine in procedural pain (3 arms), sponsored by Weihai Municipal Hospital. Primary endpoint: Maximum VAS pain score during wheal injection. Planned start Dec 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2600135195.